$BJDX
Bluejay Diagnostics, Inc. Stock $bjdx

$bjdx Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023021454 Filed on March 20, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$0.00	$0.00	$249.0K
YoY Change
Cost Of Revenue		$0.00	$200.1K
YoY Change
Gross Profit		$0.00	$48.91K
YoY Change
Gross Profit Margin			19.64%
Selling, General & Admin	$1.325M	$1.132M	$5.215M
YoY Change	-3.53%	23.38%	150.43%
% of Gross Profit			10661.27%
Research & Development	$1.355M	$1.321M	$4.152M
YoY Change	94.97%	190.27%	261.7%
% of Gross Profit			8489.2%
Depreciation & Amortization	$120.0K	$30.68K	$156.6K
YoY Change	200.27%	-21.75%	7.47%
% of Gross Profit			320.17%
Operating Expenses	$2.680M	$2.454M	$9.367M
YoY Change	29.56%	78.72%	189.98%
Operating Profit	-$2.680M	-$2.454M	-$9.318M
YoY Change	29.56%		188.46%
Interest Expense		$0.00	$0.00
YoY Change		-100.0%	-100.0%
% of Operating Profit
Other Income/Expense, Net	$139.7K	$94.55K	$20.83K
YoY Change	154.7%	1677.26%	-77.99%
Pretax Income	-$2.540M	-$2.386M	-$9.297M
YoY Change	26.15%	63.39%	166.52%
Income Tax
% Of Pretax Income
Net Earnings	-$2.540M	-$2.386M	-$9.297M
YoY Change	26.15%	63.39%	166.52%
Net Earnings / Revenue			-3733.11%
Basic Earnings Per Share	-$0.12		-$0.46
Diluted Earnings Per Share	-$0.12	-$0.12	-$0.46
COMMON SHARES
Basic Shares Outstanding	20.46M shares	20.15M shares	20.16M shares
Diluted Shares Outstanding	20.38M shares		20.16M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.782M	$10.11M	$10.11M
YoY Change	-60.4%	-46.9%	-46.9%
Cash & Equivalents	$6.782M	$10.11M	$10.11M
Short-Term Investments
Other Short-Term Assets	$2.120M	$1.673M	$1.673M
YoY Change	62.73%	3.77%	3.77%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$8.902M	$11.79M	$11.79M
YoY Change	-53.92%	-42.94%	-42.94%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.520M	$1.232M	$1.698M
YoY Change	105.25%	265.2%	403.18%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$33.44K	$35.21K	$35.21K
YoY Change	65.31%	67.52%	67.51%
Total Long-Term Assets	$1.987M	$1.733M	$1.733M
YoY Change	161.15%	383.5%	383.51%
TOTAL ASSETS
Total Short-Term Assets	$8.902M	$11.79M	$11.79M
Total Long-Term Assets	$1.987M	$1.733M	$1.733M
Total Assets	$10.89M	$13.52M	$13.52M
YoY Change	-45.78%	-35.67%	-35.67%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$388.0K	$635.8K	$635.8K
YoY Change	-45.87%	114.96%	114.96%
Accrued Expenses	$863.4K	$835.7K	$999.6K
YoY Change	45.69%	144.81%	194.55%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$4.810K	$4.810K	$4.810K
YoY Change
Total Short-Term Liabilities	$1.420M	$1.640M	$1.640M
YoY Change	8.45%	157.43%	157.43%
LONG-TERM LIABILITIES
Long-Term Debt	$14.97K	$15.82K	$15.82K
YoY Change
Other Long-Term Liabilities	$14.97K	$15.82K	$323.9K
YoY Change	-94.7%
Total Long-Term Liabilities	$14.97K	$15.82K	$339.7K
YoY Change	-94.7%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.420M	$1.640M	$1.640M
Total Long-Term Liabilities	$14.97K	$15.82K	$339.7K
Total Liabilities	$1.725M	$1.980M	$1.980M
YoY Change	8.37%	210.75%	210.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$19.54M	-$17.00M
YoY Change		120.89%
Common Stock	$2.046K	$2.022K
YoY Change		0.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$9.163M	$11.54M	$11.54M
YoY Change
Total Liabilities & Shareholders Equity	$10.89M	$13.52M	$13.52M
YoY Change	-45.78%	-35.67%	-35.67%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$2.540M	-$2.386M	-$9.297M
YoY Change	26.15%	63.39%	166.52%
Depreciation, Depletion And Amortization	$120.0K	$30.68K	$156.6K
YoY Change	200.27%	-21.75%	7.47%
Cash From Operating Activities	-$2.934M	-$2.944M	-$7.742M
YoY Change	56.27%	16.69%	77.28%
INVESTING ACTIVITIES
Capital Expenditures	$340.7K	$238.2K	$1.199M
YoY Change	-834.99%	-1442.78%	-5107.39%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$340.7K	-$238.2K	-$1.199M
YoY Change	634.99%	1242.78%	4907.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$58.80K	8.080K	$8.075K
YoY Change		-99.96%	-99.96%
NET CHANGE
Cash From Operating Activities	-$2.934M	-2.944M	-$7.742M
Cash From Investing Activities	-$340.7K	-238.2K	-$1.199M
Cash From Financing Activities	-$58.80K	8.080K	$8.075K
Net Change In Cash	-$3.333M	-3.174M	-$8.933M
YoY Change		-118.99%	-149.26%
FREE CASH FLOW
Cash From Operating Activities	-$2.934M	-$2.944M	-$7.742M
Capital Expenditures	$340.7K	$238.2K	$1.199M
Free Cash Flow	-$3.274M	-$3.182M	-$8.941M
YoY Change	78.83%	27.03%	105.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41031
CY2022	dei	Entity Registrant Name EntityRegistrantName	Bluejay Diagnostics, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-3552922
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	360 Massachusetts Avenue,
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 203
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Acton
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01720
CY2022	dei	City Area Code CityAreaCode	(844)
CY2022	dei	Local Phone Number LocalPhoneNumber	327-7078
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2022	dei	Trading Symbol TradingSymbol	BJDX
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	21361484	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20459057	shares
CY2022	dei	Auditor Firm AuditorFirmId	392
CY2022	dei	Auditor Name AuditorName	Wolf & Company, P.C.
CY2022	dei	Auditor Location AuditorLocation	Boston, Massachusetts
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10114990	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19047778	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1673480	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1612708	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	11788470	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	20660486	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1232070	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	337366	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	465514	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	35211	usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	21019	usd
CY2022Q4	us-gaap	Assets Assets	13521265	usd
CY2021Q4	us-gaap	Assets Assets	21018871	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	635818	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	295778	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	168706	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	835730	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	341384	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1640254	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	637162	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	323915	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15823	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1979992	usd
CY2021Q4	us-gaap	Liabilities Liabilities	637162	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20215288	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20215288	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20112244	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20112244	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2022	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	2011	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	28536353	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	28074484	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16997102	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7694786	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11541273	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20381709	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13521265	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	21018871	usd
CY2022	us-gaap	Revenues Revenues	249040	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	200129	usd
CY2022	us-gaap	Gross Profit GrossProfit	48911	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4152152	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1147955	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4763114	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1792482	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	451421	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	289726	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	9366687	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	3230163	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-9317776	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-3230163	usd
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-367459	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	237309	usd
CY2021	bjdx	State Grant Income StateGrantIncome	75000	usd
CY2022	us-gaap	Other Income OtherIncome	258137	usd
CY2021	us-gaap	Other Income OtherIncome	34324	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	20828	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-258135	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9296948	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3488298	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.46
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20163915	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8522422	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-4206173	usd
CY2021	bjdx	Exercise Of Common Stock Warrants ExerciseOfCommonStockWarrants	141461	usd
CY2021	bjdx	Accretion Of Series Redeemable Convertible Preferred Stock Dividend AccretionOfSeriesRedeemableConvertiblePreferredStockDividend	-127866	usd
CY2021	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	8042517	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	180339	usd
CY2021	bjdx	Fair Value Of Warrants Issued To Placement Agent In Relation To The Convertible Debentures1 FairValueOfWarrantsIssuedToPlacementAgentInRelationToTheConvertibleDebentures1	166816	usd
CY2021	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	580000	usd
CY2021	bjdx	Reclassification Of Warrants To Equity ReclassificationOfWarrantsToEquity	145953	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	68458	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt		usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	22623	usd
CY2021	bjdx	Net Of Offering Costs NetOfOfferingCosts	2750601000000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18855879	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3488298	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20381709	usd
CY2022	bjdx	Cumulative Effect Period Of Adoption Adjusted Balance CumulativeEffectPeriodOfAdoptionAdjustedBalance	-5368	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	433004	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	28876	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9296948	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	11541273	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-9296948	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3488298	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	156598	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	145719	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	433004	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	68458	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	149770	usd
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	237309	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-137	usd
CY2021	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	180339	usd
CY2021	bjdx	Debt Instrument Decrease Forgivenes DebtInstrumentDecreaseForgivenes	-5000	usd
CY2021	bjdx	Amortization Of Debt Discount Premiums AmortizationOfDebtDiscountPremiums	227007	usd
CY2021	bjdx	Gain Loss On Revaluation Of Derivative Warrant Liability GainLossOnRevaluationOfDerivativeWarrantLiability	-9676	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-84762	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	40772	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	1551637	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	14192	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	21019	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	298881	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-79150	usd
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	2000	usd
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	123102	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	336620	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	204839	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7741593	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4366758	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1199270	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23947	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1199270	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23947	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	289617	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	562842	usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	18855879	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	4500000	usd
CY2021	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	-9000	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	9079	usd
CY2022	bjdx	Payments Of Deferred Offering Costs PaymentsOfDeferredOfferingCosts	-20000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	801	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	28876	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	22623	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8075	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22526122	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8932788	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	18135417	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19047778	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	912361	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10114990	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19047778	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	364	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	150228	usd
CY2021	bjdx	Exercise Of Warrants Through Debt Principal Conversion ExerciseOfWarrantsThroughDebtPrincipalConversion	132383	usd
CY2021	bjdx	Conversion Of Convertible Debentures Into Preferred Stock ConversionOfConvertibleDebenturesIntoPreferredStock	4500000	usd
CY2021	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	8505982	usd
CY2021	bjdx	Conversion Of Amended2017 Convertible Notes ConversionOfAmended2017ConvertibleNotes	580000	usd
CY2021	bjdx	Reclassification Of Derivative Warrant Liability Into Additional Paidin Capital ReclassificationOfDerivativeWarrantLiabilityIntoAdditionalPaidinCapital	145953	usd
CY2021	bjdx	Fair Value Of Warrants Issued To Placement Agent In Relation To The Convertible Debentures FairValueOfWarrantsIssuedToPlacementAgentInRelationToTheConvertibleDebentures	166816	usd
CY2021	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	180339	usd
CY2021	bjdx	Fair Value Of Warrants Issued To Underwriters FairValueOfWarrantsIssuedToUnderwriters	2939327	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	41159	usd
CY2022	bjdx	Initial Public Offering Description InitialPublicOfferingDescription	The Company completed its initial public offering (the “IPO”) in November 2021 (“IPO Date”), whereby it sold 2,160,000 Units at a price of $10.00, with each Unit consisting of one share of the Company’s common stock, one warrant to purchase one share of common stock at an exercise price of $7.00 per share (“Class A Warrant”), and one warrant to purchase one share of common stock at an exercise price of $10.00 (“Class B Warrant”) (collectively, a “Unit”). Each warrant contained within the Units is exercisable until the fifth anniversary of the IPO Date, however, holders of Class B Warrants may exercise such warrants on a “cashless” basis after the earlier of (i) 10 trading days from closing date of the offering or (ii) the time when $10.0 million of volume is traded in the Company’s common stock, if the volume weighted average price of the Company’s common stock on any trading day on or after the closing date of the offering fails to exceed the exercise price of the Class B Warrant (subject to adjustment as described in the warrant agreement). Additionally, the underwriter of the IPO exercised their overallotment option, solely with respect to the Class A Warrants and Class B Warrants, shortly after the IPO Date which resulted in an additional issuance of 324,000 Class A Warrants and 324,000 Class B Warrants. The gross proceeds from the IPO were approximately $21.6 million and were offset by $2.8 million in offering costs.
CY2022Q4	us-gaap	Share Price SharePrice	1
CY2022	bjdx	Unrestricted Cash And Cash Equivalents UnrestrictedCashAndCashEquivalents	10100000	usd
CY2022Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	1600000	usd
CY2022Q4	us-gaap	Other Commitment OtherCommitment	2000000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.16
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt		usd
CY2022	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable		usd
CY2022	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2021Q2	us-gaap	Stock Dividends Shares StockDividendsShares	2.15	shares
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Use of Estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts and disclosures reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. The Company believes judgment is involved in accounting for the fair value-based measurement of stock-based compensation, accruals, convertible notes and warrants. The Company evaluates its estimates and assumptions as facts and circumstances dictate. As future events and their effects cannot be determined with precision, actual results could differ from these estimates and assumptions, and those differences could be material to the condensed consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Financial Statement Reclassifications</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain balances in the prior year consolidated financial statements have been reclassified to conform to the presentation in the current year consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Concentration of Credit Risk</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Cash, and cash equivalents consist of financial instruments that potentially subject the Company to a concentration of credit risk in the event of a default by the related financial institution holding the securities, to the extent of the value recorded in the balance sheet. The Company invests cash that is not required for immediate operating needs primarily in highly liquid instruments with lower credit risk.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2021Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	0	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.86
CY2022	bjdx	Weighted Average Remaining Contractual Life In Years Outstanding At Begining Balance WeightedAverageRemainingContractualLifeInYearsOutstandingAtBeginingBalance	P8Y3M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	605187	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	236279	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.8
CY2022	bjdx	Stock Issued During Period Shares Stock Option Exercised StockIssuedDuringPeriodSharesStockOptionExercised	62944	shares
CY2022	bjdx	Option To Purchase Common Stock OptionToPurchaseCommonStock	719835	usd
CY2021	bjdx	Option To Purchase Common Stock OptionToPurchaseCommonStock	503433	usd
CY2022	bjdx	Warrants For Common Stock WarrantsForCommonStock	811882	usd
CY2021	bjdx	Warrants For Common Stock WarrantsForCommonStock	811882	usd
CY2022Q4	bjdx	Class A Warrants For Common Stockin Shares ClassAWarrantsForCommonStockinShares	2484000	usd
CY2021Q4	bjdx	Class A Warrants For Common Stockin Shares ClassAWarrantsForCommonStockinShares	2484000	usd
CY2022Q4	bjdx	Class B Warrants For Common Stockin Shares ClassBWarrantsForCommonStockinShares	75400	usd
CY2021Q4	bjdx	Class B Warrants For Common Stockin Shares ClassBWarrantsForCommonStockinShares	115500	usd
CY2022Q1	bjdx	Right Of Use Assets And Lease Liabilities RightOfUseAssetsAndLeaseLiabilities	200000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	0.46	shares
CY2022	bjdx	Aggregate Intrinsic Value Exercised AggregateIntrinsicValueExercised	21354	shares
CY2022	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	43286	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	1.86
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	719835	shares
CY2020Q4	bjdx	Royalty Percentage RoyaltyPercentage	0.15	pure
CY2020Q4	bjdx	Sale Term SaleTerm	P5Y
CY2022	bjdx	Units Of Preferred Stock And Debt UnitsOfPreferredStockAndDebt	106	shares
CY2022	bjdx	Unit Purchase Agreement Offering UnitPurchaseAgreementOffering	Each Unit consisted of 100 shares of Series A redeemable, convertible preferred stock (“Series A”) at a purchase price of $100 per share and $10,000 in notes payable (the “Notes”).
CY2021Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	1060000	usd
CY2021Q1	bjdx	Debt Payment DebtPayment	268000	usd
CY2021Q1	bjdx	Debt Interest Payment DebtInterestPayment	2010	usd
CY2021Q2	bjdx	Remaining Debt Principal RemainingDebtPrincipal	580000	usd
CY2021Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	1
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	6360	usd
CY2022	us-gaap	Conversion Of Stock Amount Issued1 ConversionOfStockAmountIssued1	580000	usd
CY2021	us-gaap	Interest Expense InterestExpense	6360	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	583349	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	145837	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	183194	usd
CY2022Q4	bjdx	Discount Notes DiscountNotes	91597	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	22899	usd
CY2020Q4	us-gaap	Junior Subordinated Notes JuniorSubordinatedNotes	154000	usd
CY2020Q4	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.08	pure
CY2020Q4	bjdx	Penalty Interest PenaltyInterest	0.15	pure
CY2021	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	7443	usd
CY2022	bjdx	Common Stock Warrants Issued CommonStockWarrantsIssued	4846688	shares
CY2021Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	132383	usd
CY2021Q2	bjdx	Shares Of Common Stock SharesOfCommonStock	4166357	usd
CY2021Q4	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	21617	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.96
CY2022	bjdx	Weighted Average Remaining Contractual Life In Years Outstanding At Ending Balance WeightedAverageRemainingContractualLifeInYearsOutstandingAtEndingBalance	P6Y6M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	20578	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	495101	shares
CY2022	bjdx	Share Based Compensation Arrangements By Share Based Payment Award Options Exercisable In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisableInPeriodWeightedAverageExercisePrice	1.97
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y7M6D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	20578	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.42
CY2021Q2	bjdx	Debt Issued DebtIssued	4500000	usd
CY2021Q2	bjdx	Execution Execution	3000000	usd
CY2021Q2	bjdx	Remaining Amount RemainingAmount	1500000	usd
CY2021Q2	us-gaap	Convertible Debt ConvertibleDebt	3000000	usd
CY2021Q2	bjdx	Senior Secured Convertible Debentures Percentage SeniorSecuredConvertibleDebenturesPercentage	0.075	pure
CY2021Q3	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	1500000	usd
CY2022	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	124829	usd
CY2022Q2	bjdx	Exercise Price Per Share ExercisePricePerShare	1.25
CY2022Q2	bjdx	Dawson Warrant Term DawsonWarrantTerm	P5Y
CY2022	bjdx	Fair Value Estimated FairValueEstimated	166816	usd
CY2022	bjdx	Recognized Amortization RecognizedAmortization	266193	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	463465	usd
CY2021Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	226599	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.177
CY2022	bjdx	Warrant Term WarrantTerm	P5Y
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	180339	usd
CY2022Q1	bjdx	Payable Amount PayableAmount	200000	usd
CY2021Q4	bjdx	Warrants Granted WarrantsGranted	108000	shares
CY2021Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	356000	usd
CY2020Q4	bjdx	Warrants Granted WarrantsGranted	944160	shares
CY2021	bjdx	Warrants Exercised WarrantsExercised	4718251	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	128438	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	128438	shares
CY2022	bjdx	Class B Warrant Rights Description ClassBWarrantRightsDescription	Holders of Class B Warrants may also exercise such warrants on a “cashless” basis after the earlier of (i) 10 trading days from closing date of the offering or (ii) the time when $10.0 million of volume is traded in the Company’s common stock, if the volume weighted average price of the Company’s common stock on any trading day on or after the closing date of the offering fails to exceed the exercise price of the Class B Warrant (subject to adjustment as described in the warrant agreement).
CY2021Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.3
CY2021	bjdx	Payments Of Deferred Offering Costs PaymentsOfDeferredOfferingCosts		usd
CY2017Q4	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	476651	usd
CY2017Q4	us-gaap	Payment Of Financing And Stock Issuance Costs PaymentOfFinancingAndStockIssuanceCosts	91597	usd
CY2021	us-gaap	Temporary Equity Accretion Of Dividends TemporaryEquityAccretionOfDividends	73912	usd
CY2019Q4	us-gaap	Shares Issued SharesIssued	4455	shares
CY2019	bjdx	Warrants Issued WarrantsIssued	848	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	105000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.29
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	45000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	1.29
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	60000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	1.29
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	589786	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	433004	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	68458	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	50859	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P2Y1M6D
CY2021	bjdx	Amount Billed For Expenses AmountBilledForExpenses	4000	usd
CY2021	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty	48000	usd
CY2021	bjdx	Expense Sharing Agreement Payments To Lmbri ExpenseSharingAgreementPaymentsToLMBRI	171102	usd
CY2022Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	2000	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	2000	usd
CY2021	bjdx	Related Party Interest Expenseand Interest Payments RelatedPartyInterestExpenseandInterestPayments	3303	usd
CY2021	bjdx	Employees Cost Plus Percentage EmployeesCostPlusPercentage	0.10	pure
CY2022	bjdx	Schedule Of Amounts Earned And Due ScheduleOfAmountsEarnedAndDue	<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Year Ended <br/> December 31,</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Income from NanoHybrids included in Other Income</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">163,256</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-161"> -</div></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Cash receipts from NanoHybrids</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">143,525</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-162">-</div></td><td style="text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of December 31,</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap; text-align: center"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2022</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2021</td><td style="white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Amounts receivable from NanoHybrids included in Prepaids and Other Current Assets</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">19,731</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-163"> -</div></td><td style="width: 1%; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p>
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	163256	usd
CY2022	bjdx	Cash Received From Related Party CashReceivedFromRelatedParty	143525	usd
CY2022Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty	19731	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	337366	usd
CY2022Q4	us-gaap	Prepaid Insurance PrepaidInsurance	751979	usd
CY2021Q4	us-gaap	Prepaid Insurance PrepaidInsurance	1127062	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	160467	usd
CY2022Q4	us-gaap	Supplies Supplies	681218	usd
CY2021Q4	us-gaap	Supplies Supplies	160000	usd
CY2022Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	240283	usd
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	165179	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1673480	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1612708	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	533577	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	157938	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	302153	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	181446	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	835730	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	339384	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1828476	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	786203	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	596406	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	448837	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1232070	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y1M6D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07	pure
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	149770	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	465514	usd
CY2022Q4	bjdx	Financeleaseassetnet financeleaseassetnet	21067	usd
CY2022Q4	bjdx	Total Lease Rightof Use Assets TotalLeaseRightofUseAssets	486581	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	168706	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	4807	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	323915	usd
CY2022Q4	bjdx	Noncurrent Finance Lease Liabilities Included In Other Noncurrent Liabilities NoncurrentFinanceLeaseLiabilitiesIncludedInOtherNoncurrentLiabilities	15823	usd
CY2022	bjdx	Total Lease Liabilities TotalLeaseLiabilities	513251	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	168706	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	162991	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	100000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	100000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	25000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	556697	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	64076	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	492621	usd
CY2022Q4	us-gaap	Purchase Commitment Remaining Minimum Amount Committed PurchaseCommitmentRemainingMinimumAmountCommitted	800000	usd
CY2022	bjdx	Prepaid Percentage PrepaidPercentage	0.50	pure
CY2022	bjdx	Totaled Approximately Amount TotaledApproximatelyAmount	375000	usd
CY2022Q4	bjdx	Noncancellable Purchase Obligations NoncancellablePurchaseObligations	700000	usd
CY2022	bjdx	Toray Royalty Commitment Description TorayRoyaltyCommitmentDescription	the first sale of Cartridges, the Company will also make royalty payments to Toray equal to 15% of the net sales of the Cartridges for the period that any underlying patents exist or for 5 years after the first sale. Following the first sale, the Company will pay a one-time minimum royalty of $60,000, which shall be creditable against any royalties owed to Toray in such calendar year. The Company will pay a minimum royalty of $100,000 in each year thereafter, which are creditable against any royalties owed to Toray in such calendar year.
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	3043585	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1791043	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	190489	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	3659	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	66716	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	68564	usd
CY2022Q4	bjdx	Deferred Tax Expense DeferredTaxExpense	-1018165	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	37580	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	272106	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	97945	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	4628641	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1961211	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4628641	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1934351	usd
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	26860	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	26860	usd
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	26860	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0686	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0541	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2906	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.2588	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.012	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0053	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	2700000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	900000	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	11200000	usd
CY2022	bjdx	Federal Net Operating Losses FederalNetOperatingLosses	713000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	10900000	usd
CY2022Q4	bjdx	Carry Forward Term CarryForwardTerm	P20Y
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	6300000	usd
CY2021Q4	bjdx	Carry Forward Term CarryForwardTerm	P20Y
CY2022	bjdx	Amortized Period AmortizedPeriod	P15Y
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021	us-gaap	Revenues Revenues		usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet		usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2022	bjdx	State Grant Income StateGrantIncome		usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.46
CY2021	bjdx	Conversion Of Convertible Debentures Into Series D Preferred Stock ConversionOfConvertibleDebenturesIntoSeriesDPreferredStock		usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2022	bjdx	Exercise Of Common Stock Series B Warrants ExerciseOfCommonStockSeriesBWarrants		usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse		usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices		usd
CY2022	bjdx	Debt Instrument Decrease Forgivenes DebtInstrumentDecreaseForgivenes		usd
CY2022	bjdx	Amortization Of Debt Discount Premiums AmortizationOfDebtDiscountPremiums		usd
CY2022	bjdx	Gain Loss On Revaluation Of Derivative Warrant Liability GainLossOnRevaluationOfDerivativeWarrantLiability		usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2022	bjdx	Exercise Of Warrants Through Debt Principal Conversion ExerciseOfWarrantsThroughDebtPrincipalConversion		usd
CY2022	bjdx	Conversion Of Convertible Debentures Into Preferred Stock ConversionOfConvertibleDebenturesIntoPreferredStock		usd
CY2022	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1		usd
CY2022	bjdx	Conversion Of Amended2017 Convertible Notes ConversionOfAmended2017ConvertibleNotes		usd
CY2022	bjdx	Reclassification Of Derivative Warrant Liability Into Additional Paidin Capital ReclassificationOfDerivativeWarrantLiabilityIntoAdditionalPaidinCapital		usd
CY2022	bjdx	Fair Value Of Warrants Issued To Placement Agent In Relation To The Convertible Debentures FairValueOfWarrantsIssuedToPlacementAgentInRelationToTheConvertibleDebentures		usd
CY2022	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims		usd
CY2022	bjdx	Fair Value Of Warrants Issued To Underwriters FairValueOfWarrantsIssuedToUnderwriters		usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid		usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber		shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
CY2022	us-gaap	Related Party Transaction Expenses From Transactions With Related Party RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty		usd
CY2022	bjdx	Expense Sharing Agreement Payments To Lmbri ExpenseSharingAgreementPaymentsToLMBRI		usd
CY2022	bjdx	Related Party Interest Expenseand Interest Payments RelatedPartyInterestExpenseandInterestPayments		usd
CY2021	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction		usd
CY2021	bjdx	Cash Received From Related Party CashReceivedFromRelatedParty		usd
CY2021Q4	us-gaap	Related Party Transaction Due From To Related Party RelatedPartyTransactionDueFromToRelatedParty		usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent		usd
CY2022Q4	bjdx	Lessor Operating Lease Paymentstobe Received Thereafter LessorOperatingLeasePaymentstobeReceivedThereafter		usd
CY2021Q4	bjdx	Deferred Tax Expense DeferredTaxExpense		usd
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment		usd
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001704287

Files In Submission

Name	View Source	Status
0001213900-23-021454-index-headers.html	Edgar Link	pending
0001213900-23-021454-index.html	Edgar Link	pending
0001213900-23-021454.txt	Edgar Link	pending
0001213900-23-021454-xbrl.zip	Edgar Link	pending
bjdx-20221231.xsd	Edgar Link	pending
bjdx-20221231_cal.xml	Edgar Link	unprocessable
f10k2022ex31-1_bluejaydiag.htm	Edgar Link	pending
f10k2022ex31-2_bluejaydiag.htm	Edgar Link	pending
f10k2022ex32-1_bluejaydiag.htm	Edgar Link	pending
f10k2022ex32-2_bluejaydiag.htm	Edgar Link	pending
f10k2022_bluejaydiag.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
bjdx-20221231_lab.xml	Edgar Link	unprocessable
bjdx-20221231_def.xml	Edgar Link	unprocessable
f10k2022_bluejaydiag_htm.xml	Edgar Link	completed
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bjdx-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BJDX
Bluejay Diagnostics, Inc. Stock $bjdx

2023 Q1 Form 10-K Financial Statement

#000121390023021454 Filed on March 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BJDX Bluejay Diagnostics, Inc. Stock $bjdx

2023 Q1 Form 10-K Financial Statement

#000121390023021454 Filed on March 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BJDX
Bluejay Diagnostics, Inc. Stock $bjdx